Integrative genomic approaches identify IKBKE as a breast cancer oncogene. - Wikidata - wikimedia - TriplyDB

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

http://www.wikidata.org/entity/Q33287979

about

Emerging roles for the non-canonical IKKs in cancer β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis Identification of PP2A complexes and pathways involved in cell transformation SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma Genomic screening with RNAi: results and challenges Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas The NF-κB Pathway and Cancer Stem Cells Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells Human Cyclin-dependent Kinase 2-associated Protein 1 (CDK2AP1) Is Dimeric in Its Disulfide-reduced State, with Natively Disordered N-terminal Region Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes Copper is required for oncogenic BRAF signalling and tumorigenesis PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKε MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy Deciphering fact from artifact when using reporter assays to investigate the roles of host factors on L1 retrotransposition Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module The landscape of somatic copy-number alteration across human cancers.COT drives resistance to RAF inhibition through MAP kinase pathway reactivation Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 Inflammation meets cancer, with NF-κB as the matchmaker TNF-insulin crosstalk at the transcription factor GATA6 is revealed by a model that links signaling and transcriptomic data tensors.A high-throughput assay for phosphoprotein-specific phosphatase activity in cellular extracts.An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection.Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival Targeting pathways downstream of KRAS in lung adenocarcinoma.WIPI3 and WIPI4 β-propellers are scaffolds for LKB1-AMPK-TSC signalling circuits in the control of autophagy.Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.Towards improved cancer diagnosis and prognosis using analysis of gene expression data and computer aided imaging.Biology-driven cancer drug development: back to the future PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling CK1epsilon is required for breast cancers dependent on beta-catenin activity.PTK6 regulates IGF-1-induced anchorage-independent survival.IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.

P2860

Q24305225-C3AB2ED0-9A04-45A4-A126-CF115E354E1D Q24306274-7D06BF70-4DE9-4E05-BFE6-F5DB7932175E Q24316472-0C64E704-F91B-4F1C-A269-E0E03B6EC7E2 Q24316768-E61FAD97-A377-450E-ACCB-566A42D64C58 Q24322118-77E4244C-67F4-43FD-8191-77657011779F Q24626537-FB64D480-2B8D-4BB6-83BE-31D8245BC88A Q24657474-5B62B7AA-36BE-480C-BF54-F9D37B25743B Q26750605-FA78984E-57B2-40C0-BEA4-B75592FE5687 Q26801686-C0736C56-3D26-4866-B0E2-4C759280BE9B Q27318498-1BF0C9EE-D602-4BFA-AC57-8B4F27ACDC58 Q27320024-AA5B7EE0-F274-412C-902D-44A3D8A13A30 Q27678086-1E8CD408-AAD3-4004-9946-D289CE232AF1 Q28072745-DACD1BCA-1793-4C76-9548-E27940F9B499 Q28237892-397A6004-4514-4577-81EB-CF4245ED632D Q28253621-8ACAD44F-33B2-48FC-9D66-F19A562D7A3D Q28259003-178E1CDF-0980-4A11-96E5-B834EA3081BC Q28302027-DF298BE4-BE1C-4DBF-A103-96DD872EC469 Q28481686-5D22C4D9-21D6-4C71-91F3-22579FE7A876 Q28552218-984C6DC3-CCE5-4E0C-932C-4B320C037192 Q28593628-6770B5AB-F843-4FBD-8C12-993EDEA9D806 Q28828801-12AE8D53-1416-43DE-89FA-494FAA8FF586 Q29547648-E048F3E7-98E9-44DD-B09B-1EF6F980AEF0 Q29615032-297C87CD-F764-40C5-84F6-EC29118F4B81 Q29617043-C0446F1D-7CFD-4F7A-98EF-C2FD24EC0C8A Q29620242-B87F8A56-A80D-4C0D-9F8D-A8A1B1A045E3 Q30276641-20A3F435-4615-4C35-BAA5-FECF0573FE48 Q30414621-2D81DDC0-0AFF-466F-BE7A-61E2B94663F9 Q30415276-9385B3C0-BEAA-448D-92CC-EB275DB45CF5 Q30452448-57E33E00-BF11-4628-8641-496052301B4E Q30495169-D65B698A-B5A5-4AFF-96D1-4BFB0730CD1F Q30597330-6C0B9537-5331-479D-8E65-0F43EC541B72 Q30854841-ADEA60C0-2083-493E-A3A5-1E88E33A9BE5 Q33456429-808CF7FD-E062-4477-9DB5-DDC7C5C50D5D Q33459037-544A8AFF-9D21-418D-A332-9C30C51CA104 Q33552888-F789F0C1-E153-4248-8481-DDEEA0C2965B Q33594693-AE4E3239-815C-4B6E-81CA-12587C987125 Q33620584-3EFBB9EE-18BD-4994-9752-BA6580542CDD Q33644326-527A04D7-8FF5-4DBC-A3D3-44D5945CC9A1 Q33662031-F723FAD3-4248-428D-9C3B-2036DCCD361F Q33717414-D7D7850E-D2BA-4A09-B9AE-977A4A4E2B1B

P2860

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

http://www.wikidata.org/entity/Q33287979

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@ast

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@en

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@nl

type

label

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@ast

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@en

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@nl

altLabel

Integrative genomic approaches identify IKBKE as a breast cancer oncogene

@en

prefLabel

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@ast

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@en

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@nl

P1433

Q33287979-0C894B28-8C16-418E-8E4D-89651939F616

P1476

Q33287979-95202734-8A58-48A2-938E-E0645ED9A96A

P2093

Q33287979-00BCDC90-4647-41CD-AD10-E1712657926E

Q33287979-0C0DD253-5298-4907-948A-79288C253D57

Q33287979-12293185-A84C-4037-AE69-1C57A5F550EA

Q33287979-1EFB30AD-32A2-4F16-A2B2-7FC7ED48172B

Q33287979-27CD9C3D-A460-404B-BF79-05E4331621EC

Q33287979-335E4072-1174-4908-8B7A-73A296CA267C

Q33287979-52BDA14E-2D0A-4B80-8038-0CF2F277469B

Q33287979-55B43876-1C36-412C-A118-A69604ACBAE4

Q33287979-5AC8B152-F2EB-4D88-B340-686CB1F5E10F

Q33287979-5E4D3B22-E5B6-49E5-AE1E-977A15DE8C08

P304

Q33287979-59675972-4B9C-4D73-9B45-78050B4B27BD

P31

Q33287979-0248BDB7-3DBA-4870-9A3D-4DB0E8AA32B1

P356

Q33287979-FE720606-B74C-419A-AC99-28E49964D426

P407

Q33287979-D9AA187F-2519-4812-9E75-1B303E95E12D

P433

Q33287979-10F0F0CC-DAC7-4D97-9896-7536D10D73B5

P478

Q33287979-B7590303-98CF-41BF-9A30-46FD6B2805C5

P50

Q33287979-28A56574-AC66-4932-9F20-CDCB6AB4766A

Q33287979-A6E8A7D0-2462-49C9-8501-B81C98574D48

Q33287979-AF74BCF4-1840-4920-9D40-ECC90811C987

Q33287979-BA7BE0D7-F993-495A-8AEA-C1B23C9D0C9C

Q33287979-C8AD515D-3291-4C9A-A874-481C901BB6C4

Q33287979-CA937093-E376-4750-B0E0-CFB57CA2AF10

P577

Q33287979-4C371C0D-72C1-40EB-980D-EDFF88A48DDD

P5875

Q33287979-E4B9EA98-F56E-47F5-93D7-3A4FF825150F

P698

Q33287979-852CDBDB-51D9-4B73-8109-B7AE2ACE002A

P356

J.CELL.2007.03.052

P1433

P1476

Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

@en

P2093

Andrea L Richardson

http://www.w3.org/2001/XMLSchema#string

Carly J Stewart

http://www.w3.org/2001/XMLSchema#string

David E Hill

http://www.w3.org/2001/XMLSchema#string

David E Root

http://www.w3.org/2001/XMLSchema#string

Greg Hinkle

http://www.w3.org/2001/XMLSchema#string

Ian F Dunn

http://www.w3.org/2001/XMLSchema#string

Jean J Zhao

http://www.w3.org/2001/XMLSchema#string

Jennifer K Grenier

http://www.w3.org/2001/XMLSchema#string

Jun Yao

http://www.w3.org/2001/XMLSchema#string

Kornelia Polyak

http://www.w3.org/2001/XMLSchema#string

P304

1065-1079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2007.03.052

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Tomoko Hirozane-Kishikawa

Matthew Meyerson

Levi A Garraway

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6263164

http://www.w3.org/2001/XMLSchema#string

P698

17574021

http://www.w3.org/2001/XMLSchema#string